Drug profile · INN
zolmitriptan
ZOLMITRIPTAN
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
zolmitriptan (ZOLMITRIPTAN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: nasal. Current US regulatory status: approved.
Key facts
INN zolmitriptan
Brand ZOLMITRIPTAN
Route NASAL
Formulation TABLET, ORALLY DISINTEGRATING
Originator Amneal Pharma Europe Ltd
Related patents
Search patents →Frequently asked questions
What is zolmitriptan?
zolmitriptan (ZOLMITRIPTAN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for zolmitriptan?
ZOLMITRIPTAN is a marketed brand name for zolmitriptan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of zolmitriptan?
zolmitriptan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.